mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-11 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-10 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-10 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
8e-10 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-09 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
8e-09 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |